Production (Stage)
OnKure Therapeutics, Inc.
OKUR
$2.88
$0.020.70%
NASDAQ
| 03/31/2025 | 06/30/2024 | 03/31/2024 | |||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -12.73% | -3.20% | -35.57% | ||
| Total Receivables | -- | -- | -- | ||
| Inventory | -- | -- | -- | ||
| Prepaid Expenses | -32.60% | 49.22% | -11.05% | ||
| Finance Division Loans and Leases Current | -- | -- | -- | ||
| Total Finance Division Other Current Assets | -- | -- | -- | ||
| Other Current Assets | -- | -- | -- | ||
| Total Current Assets | -13.12% | 4.79% | -32.75% | ||
|
|
|||||
| Total Current Assets | -13.12% | 4.79% | -32.75% | ||
| Net Property, Plant & Equipment | -10.81% | -7.92% | -7.43% | ||
| Long-term Investments | -- | -- | -- | ||
| Goodwill | -- | -- | -- | ||
| Total Other Intangibles | -- | -- | -- | ||
| Finance Div Loans & Leases LT | -- | -- | -- | ||
| Total Finance Div Other LT Assets | -- | -- | -- | ||
| Total Other Assets | 0.00% | -3.92% | -12.07% | ||
| Total Assets | -13.08% | 3.86% | -31.36% | ||
|
|
|||||
| Total Accounts Payable | -21.02% | 128.02% | 6.03% | ||
| Total Accrued Expenses | -16.10% | 162.65% | -53.11% | ||
| Short-term Debt | -- | -- | -- | ||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | ||
| Finance Division Debt Current | 1.87% | 1.89% | 1.92% | ||
| Total Finance Division Other Current Liabilities | -- | -- | -- | ||
| Total Other Current Liabilities | -- | -- | -- | ||
| Total Current Liabilities | -16.57% | 133.90% | -23.80% | ||
|
|
|||||
| Total Current Liabilities | -16.57% | 133.90% | -23.80% | ||
| Long-Term Debt | -- | -- | -- | ||
| Short-term Debt | -- | -- | -- | ||
| Capital Leases | -25.50% | -13.35% | -11.59% | ||
| Finance Division Debt Non Current | -- | -- | -- | ||
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | ||
| Total Other Liabilities | -- | -- | -- | ||
| Total Liabilities | -16.65% | 222.40% | -23.07% | ||
|
|
|||||
| Common Stock & APIC | 1.06% | 559.20% | 55.98% | ||
| Retained Earnings | -10.29% | -12.67% | -9.34% | ||
| Treasury Stock & Other | -- | -- | -- | ||
| Total Common Equity | -12.69% | -11.07% | -9.25% | ||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | ||
| Preferred Stock Non Redeemable | -- | -- | -- | ||
| Preferred Stock Convertible | -- | 0.00% | 0.00% | ||
| Preferred Stock, Others | -- | -- | -- | ||
| Total Preferred Equity | -- | 0.00% | 0.00% | ||
|
|
|||||
| Total Common Equity | -12.69% | -11.07% | -9.25% | ||
| Total Preferred Equity | -- | 0.00% | 0.00% | ||
| Total Minority Interest | -- | -- | -- | ||
| Total Equity | -12.69% | -66.34% | -33.66% | ||
|
|
|||||